acetylsalicylic acid/blæðing

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

Bls 1 frá 59 niðurstöður

IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Between 30 and 50% of patients who contract COVID 19 will be asymptomatic or oligosymptomatic. This fact will not give rise to the consult, and will directly affect a notorious sub-registration of the cases. The second, even more disturbing, premise is that these patients are as contagious as the

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Omega 3 and Ischemic Stroke; Fish Oil as an Option

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Introduction and Background According to the Center of Disease Control and Prevention, stroke is the 5th leading cause of mortality in the US, and a leading cause of significant long-term disability where almost 50% of stroke survivors, age 65 and above, suffer from disabling decrease in mobility.

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

It is a investigator-initiated, compassionate use, prospective, phase 2b, non randomized, open-label, proof of concept study in which the investigators will evaluate the effects of compassionate-use treatment with IV tirofiban, associated with acetylsalicylic acid PO, clopidogrel PO and fondaparinux

PercutaNEOus Coronary Intervention folloWed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Based on current scientific evidence, acute coronary syndrome (ACS) subjects should be treated with dual antiplatelet therapy (DAPT), which consists of the association of acetylsalicylic acid (ASA) with an oral antagonist of platelet P2Y12 receptor. Clinical trials have shown that DAPT reduces

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

EXISTING KNOWLEDGE AND MAIN ASSUMPTIONS OF THE PROJECT. Atherosclerosis is the most common cause of peripheral artery disease (PAD). The first symptom of PAD is intermittent claudication (IC), which is characterized by the occurrence of pain, cramps, numbness, and discomfort in the lower limb

Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Inflammatory Markers in Hysterectomies

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Rationale: Thromboembolic- and bleeding events can occur after TAVI and can have great consequences. There is currently no evidence-based guideline on prevention of thromboembolic events after TAVI and the current standard of care with DAPT 3-6 months is based on expert opinion. Recently multislice

Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Research question To study whether dietary supplementation with L. reuteri ATCC PTA 4659 (Lr4659) is safe and can reduce the relapse rate and have a positive effect in patients with ulcerative colitis (UC). Lr4659 is a naturally occurring strain of human origin. It is a typical member of the L.

Vascular Healing After Implantation of FANTOM Bioresorbable Scaffold in STEMI: A FANTOM STEMI Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The aim of the study is to evaluate the acute safety and feasibility of implantation of the sirolimus-eluting bioresorbable Fantom scaffold BVS in the setting of ST segment elevation myocardial infarction (STEMI), as well as the mid and long-term clinical efficacy and healing pattern of the device,

Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

INTRODUCTION Post-implantation syndrome is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm.1 PIS is mainly a clinical condition associated with the implantation of an endograft and is diagnosed by the presence of fever

Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Randomization to study drugs shall be performed using an online database system for data collection; the assigned arm and the randomisation code will be generated after entering basic patient data based on a predefined randomization scheme. Concomitant therapy. Acetylsalicylic acid - 500 mg i.v.

Haemostasis Management of Abdominal Aortic Procedures

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Despite the fact that interventional therapy of vascular lesions (endovascular and hybrid procedures) is becoming more and more common, angioplasties involving major vessels have to be still managed as surgical procedures associated with extreme high demand for transfusion, this applies especially

GLOBAL LEADERS Adjudication Sub-Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The GLOBAL LEADERS trial was designed to determine the benefits and risks of an antithrombotic regimen using ticagrelor 90 mg BID combined with low-dose (75 mg OD) acetylsalicylic acid (ASA) for one month followed by ticagrelor 90 mg BID alone for 23 months, compared to conventional dual

Fyrri
1
2
3
4
Næst

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum